Think it's going to take Genius to workout how much this new acquisition is going to cost. This is what's holding SEI back. No hurry to buy in and someone is keeping this back.
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial